Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allcure Kangtai appears to refer to Allcure Kangtai Proton Technology, a China-based healthcare technology and oncology company associated with Beijing Allcure Medical Technology. The company focuses on radiotherapy, tumor diagnosis and treatment center development, and related healthcare technology infrastructure rather than drug discovery. Publicly available sources indicate it uses the mdaccAutoPlan radiotherapy planning algorithm and cloud-based radiotherapy tools, and it contracted with Mevion for a compact proton therapy system to support cancer treatment in China. The business is best characterized as a commercial-stage oncology technology and treatment-enablement company operating in radiation oncology and proton therapy deployment. Evidence for a traditional biotech/pharma pipeline is limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allcure Kangtai.